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ABSTRACT 
This study aimed to identify the main comorbidities in elderly chagasic patients treated in a reference service and identify possible associations 
between the clinical form of Chagas’ disease and chronic diseases. Ninety patients aged 60 years-old or over were interviewed and their clinical 
diagnoses recorded. The study population profile was: women (55.6%); median age (67 years); married (51.1%); retired (73.3%); up to four years’ 
education (64.4%); and earning less than two minimum wages (67.8%). The predominant forms of Chagas’ disease were the cardiac (46.7%) and 
mixed forms (30%). There was a greater proportion of mild cardiac dysfunction (84.1%), frequently in association with megaesophagus. The mean 
number of concurrent diseases was 2.856 ± 1.845, and 33% of the patients had four or more comorbidities. The most frequent were systemic arterial 
hypertension (56.7%), osteoporosis (23.3%), osteoarthritis (21.2%) and dyslipidemia (20%). Positive correlations were verified between sex and 
comorbidities and between age group and comorbidities.
Key-words: Chagas’ disease. Ageing. Elderly. Comorbidities.  
RESUMO 
Este trabalho objetivou avaliar o perfil sociodemográfico e identificar as principais co-morbidades de idosos chagásicos, buscando associação entre forma 
clínica da doença de Chagas e enfermidades crônicas. Foi realizada entrevista e levantamento dos diagnósticos clínicos de 90 chagásicos com idade ≥ 60 
anos. Encontrou-se: mulheres (55,6%), mediana de 67 anos, casados (51,1%) e renda mensal inferior a dois salários-mínimos (67,8%). A forma clínica 
predominante foi a cardíaca (46,7%), seguida da mista (30%). Houve maior proporção de cardiopatia leve (84,1%), sendo frequente a associação com 
megaesôfago. Trinta e três por cento apresentavam quatro ou mais co-morbidades, dentre elas: hipertensão arterial (56,7%), osteoporose (23,3%), 
osteoartrite (21,2%) e dislipidemia (20%). Obteve-se correlação positiva entre gênero e co-morbidades, faixa etária e co-morbidades.
Palavras-chaves: Doença de Chagas. Envelhecimento. Idosos. Co-morbidades.  
When vectorial and transfusional transmission of Chagas’ 
disease is controlled, acute cases of the disease gradually cease to 
appear and the number of young people infected falls11. However, 
the challenge of treating millions of infected individuals during the 
chronic phase of the disease remains. A large proportion of these 
individuals are elderly and are therefore predisposed to other 
chronic conditions apart from Chagas’ disease. In Brazil, 80% 
of elderly individuals have at least one non-transmittable chronic 
disease and around 15% have five or more16 25. Furthermore, 
elderly individuals tend to have greater physiological and 
immunological susceptibility, particularly to infection, which 
contributes to a reduction in their physical capacity and reduces 
their independence15.
Special emphasis should be given to the coexistence of Chagas’ 
disease with the ageing process in people suffering from this 
condition. In light of the decline that occurs with advancing age, 
there may be specific aspects of the ageing process in Chagas’ 
sufferers that need to be more clearly understood11 26. On the one 
hand, these individuals bear the stigma of the disease13, as well the 
biological and psychosocial consequences18 23 of the evolution of an 
endemic disease that affects the cardiac and digestive systems. There 
is evidence that heart failure (HF) in most elderly chagasic patients 
is caused by cardiac changes typical of ageing, together with other 
diseases of the heart and circulatory system12 19. However, according 
to Rocha et al47, elderly chagasic patients without advanced cardiac 
dysfunction have good functional health, similar to that of young 
chagasic patients at the same clinical stage.
The fact that chronic diseases often coexist results in patients 
making heavy use of health services and medication and, 
consequently, at risk of practicing polypharmacy, a condition 
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defined as the use of one medication to correct the adverse effect 
of another one and/or daily use of five or more medications per 
individual3 10 32 52. In light of this, the combination of Chagas’ disease 
and other illnesses may increase morbidity and mortality and lead 
to a reduction in the quality of life in these elderly patients1 24 29. 
The aim of this study was to identify the principal comorbidities in 
elderly chagasic patients being treated in a reference service and 
to determine their sociodemographic profile, as well as establish 
whether an association exists between the clinical form of the 
disease and other chronic illnesses and whether this depends 
on sex and age.
MATERIAL AND METHODS
This study was conducted in the Outpatient Unit of the Group 
for Studies into Chagas’ Disease (GEDoCh), Clinic Hospital of 
Campinas State University (HC/UNICAMP), and approved by the 
Research Ethics Committee of the Faculty of Medical Sciences, 
Campinas State University (n: 124599). The study population 
consisted of 90 men and women aged 60 years-old or over who 
were positive for Chagas’ disease in at least two serological 
tests. Patients with inconclusive serology, cognitive alterations 
or clinical decompensation were not included in the study. A 
questionnaire was prepared to determine the sociodemographic 
profile of the study population using other instruments cited 
in the literature25 26 27. Data was collected from February 2007 
to October 2007 in face-to-face interviews after the patients’ 
appointments, which had been previously scheduled. Clinical 
data were collected from the patients’ medical records.
The chronic forms of Chagas’ disease had been previously 
classified as indeterminate, cardiac, digestive and mixed (i.e., 
cardiac and digestive, with the presence of megaesophagus 
and/or megacolon). This classification complies with the criteria 
defined by the World Health Organization/Pan American Health 
Organization (WHO/PAHO), which are used to determine whether 
cardiac dysfunction is present and to classify its severity according 
to the following different grades of involvement of the disease38.
Grade 1, chagasic infection without clinical, radiological or 
electrocardiographic indicators of cardiac lesions;
Grade 2, moderate or no symptoms; normal X-rays, 
or X-rays indicating mild cardiac hypertrophy; abnormal 
electrocardiogram (ECG), e.g., a complete right-branch bundle 
block (RBBB), changes in ventricular repolarization and 
ventricular extrasystoles; 
Grade 3, evident symptoms, moderate cardiac hypertrophy 
and changes in the ECG, such as RBBB with a shift in the mean 
cardiac electrical axis and regions of electrical inactivity;
Grade 4, very pronounced symptoms including heart failure; X-
ray examination reveals advanced cardiomegaly and the ECG shows 
severe, multiple abnormalities, such as complex arrhythmias and 
extensive regions of electrical inactivity.
Based on this classification, the cardiac form of Chagas’ 
disease was further divided into mild or serious. The mild form 
is considered to be present in individuals who satisfy the criteria 
used to define WHO/PAHO grades 1 and 238, while for the serious 
form, individuals must have the characteristics dertermined for 
grades 3 and 4.
For the statistical analysis, the Chi square and Fisher exact 
tests were used to determine whether there was an association 
between the variables being studied. When required, the Student 
t test was used for normal distributions and the Mann Whitney 
test in all other cases. The Epi Info program (version 6.04d) was 
used, with a significance level of p < 0.05.
RESULTS
The majority (55.6%) of the interviewees were women; 70% 
were between 60 and 69 years of age; the median age was 67 
years-old (mean 67.7 ± 6.5); 73.3% were retired; 64.4% had only 
attended school for up to four years; and 67.8% had a monthly 
income of less than two minimum monthly wages. A relatively 
high percentage of them were found to be illiterate (30%), the 
majority were married (51.1%) and almost 30% were widows or 
widowers. The predominant clinical form of Chagas’ disease was 
the cardiac form (46.7%), followed by the mixed (30%), digestive 
(13.3%) and indeterminate (10%) forms. Of the individuals with 
cardiac dysfunction, 84.1% and 15.9% presented with the mild 
and serious forms, respectively. Of those with the digestive form 
of the disease, 58.3% were suffering from megaesophagus, 16.7% 
from megacolon and 25% from both complications together. 
For the mixed form, the predominant combination was cardiac 
dysfunction and megaesophagus (48.1%).
Among females, a similar distribution was verified for both 
the mixed (36%) and cardiac (34%) forms of the disease. A 
higher incidence of the cardiac form (62.5%) was veried among 
elderly men. The digestive and indeterminate forms predominated 
among women, with no statistically significant difference observed 
between the distribution of either form (p=0.169487). In subjects 
under the age of 67 years-old, the cardiac (51.9%), digestive 
(15.4%) and indeterminate (13.5%) forms predominated. In 
those aged 67 years-old or over, there was a greater (44.7%) 
proportion of the mixed form  (Table 1).
In the individuals interviewed, an average of 2.8 ± 1.8 illnesses 
were present together with Chagas’ disease. The groups were divided 
into two categories according to the number of comorbidities: those 
with less than four (66.7%) and those with equal to or more than 
four (33.3%). With regard to the type of concurrent chronic disease, 
the following were most observed: systemic arterial hypertension 
(SAH) (56.7%), osteoporosis (23.3%), osteoarthritis (21.2%), 
dyslipidemia (20%), ischemic heart disease, diabetes mellitus 
(DM) and dyspepsia in equal proportions (10%), as well as HF 
and hypothyroidism, which had an incidence of 7.78% each (Table 
2). Other diagnoses were made in smaller proportions: depressive 
disorders (6.7%), chronic venous insufficiency (6.1%), obesity 
(5.6%), cerebrovascular disease (4.4%), cataracts (4.1%) and 
chronic obstructive pulmonary disease (3.3%).
The number and type of comorbidities varied according to 
sex. A higher incidence of women with up to four comorbidities 
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TABLE 1
Distribution of the clinical form of Chagas’ disease in elderly chagasic patients 
interviewed in the GEDoCh Outpatient Unit according to sex, age group, level of 
education and income.
                                               Clinical Form of Chagas’ disease
                             indeterminate         cardiac               digestive                mixed
SD variables n % n % n % n %
Sex    
male 3 7.5 25 62.5 3 7.5 9 22.5
female 6 12.0 17 34.0 9 18.0 18 36.0
Age group    
< 67 years-old 7 13.5 27 51.9 8 15.4 10 19.2
> 67 years-old 2 5.3 15 39.5 4 10.5 17 44.7
Level of education    
illiterate 0 0.0 11 40.7 6 22.2 10 37.1
< 4 years 8 13.8 27 46.6 6 10.3 17 29.3
> 4 years 1 20.0 4 80.0 0 0.0 0 0.0
Income    
< 2 MMW 5 8.2 28 46.0 9 14.7 19 31.1
> 2 MMW 3 11.1 13 48.1 3 11.1 8 29.7
N/A 1 50.0 1 50.0 0 0.0 0 0.0
GEDoCh: Group for Studies into Chagas’ disease, SD: sociodemographic, 
MMW: minimum monthly wage, N/A: information not available.
TABLE 2
Distribution of comorbidities in elderly chagasic patients interviewed in the GEDoCh 
Outpatient Unit.
Comorbidities Distribution Percentage (%)




Ischemic heart disease 9 10.0
Diabetes mellitus 9 10.0
Dyspepsia 9 10.0
Heart failure 7 7.78
Hypothyroidism 7 7.78
GEDoCh: Group for Studies into Chagas’ disease.
TABLE 3
Number of comorbidities in elderly chagasic patients interviewed in the GEDoCh 
Outpatient Unit by gender and age group.
                                              Gender                                       Age Group
              male                    female            < 67 years-old    >67 years-old
Comorbidities n % n % n % n %
< 4 31 77.5 29 58.0 38 73.0 22 57.9
> 4 9 22.5 21 42.0 14 23.0 16 42.1
Total 40 100 50 100 52 100 38 100
GEDoCh: Group for Studies into Chagas’ disease, UNICAMP.
(64%) was observed, while for men, the most frequent number 
of comorbidities was one, for which the incidence was 42.5%. It 
should be noted that only dyspepsia, which was present in 17.5% 
of men and 4% of women, was more common in men than in 
women. There was also a variation in the number of comorbidities 
according to age group. Individuals aged 67 or under had a higher 
proportion of one (30.8%) or two (27%) concurrent illnesses, 
while those aged over 67 had a greater proportion of three 
(21%) or four (18.4%). The average number of comorbidities 
in individuals aged 67 or under was 2.5 ± 1.6; the corresponding 
figure for those over 67 was 3.2 ± 2.0. However, the differences 
between the total number of comorbidities for the various age 
groups was not statistically significant (p = 0.119489).
When the patients were divided into two groups according to 
the number of comorbidities (< 4 and ≥ 4), the mean number 
of concurrent diseases for women was 3.2 ± 1.8, and for men, 
2.3 ± 1.7 (p=0.006064). Among patients with ≥ 4 comorbidities 
(Table 3), women predominated, with 42% being classified in this 
category. The percentage of men with less than four concurrent 
illnesses was 77.5%, while the corresponding figure for women 
was 58% (p=0.119489). Regarding age group, the mean number 
of concurrent illnesses for patients up to 67 years of age was 2.5 
± 1.6, while the corresponding figure for those above this age 
was 3.2 ± 2.0 (p=0.119489).
The incidence of the most frequent illnesses varied according 
to the age group: SAH was present in 58.8% of individuals aged 
67 or under, osteoarthritis in 52.6%, DM in 55.5%, dyspepsia  in 
66.7% and hypothyroidism in 57.1%. The oldest patients presented 
with more ischemic heart disease (88.9%), dyslipidemia 
(61.1%), HF (85.7%) and osteoporosis (57.1%). Concerning 
the distribution of comorbidities by age group, a statistically 
significant difference was observed for ischemic heart disease 
(p=0.0038315) and HF (p=0.0209032) in individuals aged 
over 67. Cerebrovascular disease showed a tendency toward an 
association when individuals aged 60 to 67 were compared with 
those aged over 67 years (p=0.06071263).
The number of hospitalizations was also examined and 
17.8% of the subjects had been hospitalized at least once in 
the year prior to the interview. Decompensated heart failure 
was the cause of hospitalization in 68.7% of the patients. Other 
causes included cerebrovascular disease, pneumonia, pleural 
hemorrhage and surgery, which together accounted for 31.2% 
of all hospitalizations. The majority of individuals who had been 
admitted to hospital in the year prior to the interview were men 
(56.3%); of these, 75% were aged over 67 years-old, 50% had 
attended school for up to four years and 81.3% had a monthly 
income of less than twice the minimum monthly wage. The 
predominant clinical forms of Chagas’ disease were the cardiac 
(50%) and mixed (37.5%) forms.
The types of therapeutic agents most frequently used by 
the patients in our study were angiotensin-converting enzyme 
inhibitors (ACEIs), used by 46.7% of the subjects; diuretics 
(45.6%); platelet aggregation inhibitors (35.6%); proton pump 
inhibitors (22.2%); and antiarrhythmic agents (20%). Other 
medications used less frequently were H
2
 receptor antagonists, 
antidepressants, antidiabetic agents, calcium channel blockers, 
benzodiazepines and levothyroxine. Only 8.9% of the subjects 
used sodium alendronate, and 15.6% calcium carbonate. The 
majority (74.4%) of the patients reported using up to four 




This study permitted a sociodemographic pattern to be 
identified for elderly Chagas’ disease sufferers attended at the 
GEDoCh Outpatient Unit. The following groups predominated in 
the study population: women; patients between 60 and 69 years 
of age; widows and widowers; patients with a limited education; 
and retired patients. This profile may be associated with a cohort 
phenomenon involving people who live in very specific conditions 
that contribute to the appearance and development of the disease. 
According to Dias13, in the context of the political and social 
evolution in the South American continent, the presence of Chagas’ 
disease in this population reflects the social inequality and poor 
conditions to which this population is exposed.
The profile detected in this study is similar to that of a cohort 
of elderly subjects living in an area endemic for Chagas’ disease 
(Bambuí, MG)26 29. In a survey by Lima-Costa et al26, the following 
groups predominated: women (60%); patients with a median 
age of 67 years-old; married patients (48.9%); widows and 
widowers (35.4%); patients with a monthly income between 1 
and 2.99 times the minimum monthly wage (62%); and patients 
who had only attended school for up to 4 years (89.1%). 
According to Neri35, there are more elderly women than men 
and the former are financially worse off, less educated and in 
worse health than the latter. This situation represents what the 
literature on gerontology refers to as the feminization of ageing, 
which is a result of the greater life expectancy at birth and at 
60, 70 and 80 years of age35 40. In general, old age represents a 
different experience for men and women, both subjectively and 
in terms of standard of living, diseases and death. However, the 
current literature concerning factors differentiating health in 
the elderly that addresses the issue of sex is still insufficient42 43 
48 for complete understanding of this phenomenon.
With regard to financial income, elderly individuals in Brazil 
have limited purchasing power, few pension benefits or allowances 
or even no income at all2. The majority of chagasic patients live 
in unhealthy conditions and sometimes have to work long hours 
to survive14 18. In view of this, the social impact of the disease 
in terms of its repercussions for occupational health18 must be 
taken into account, as 81.3% of the elderly sufferers of the disease 
interviewed earned less than two minimum monthly wages.
Regarding education, 30% of the elderly chagasic patients were 
illiterate and the majority only had up to four years of education 
(64.4%). In the study by Oliveira et al37, in which the mean age was 
48.1 years-old, the majority of the participants had not completed 
primary school (68.6%) and the percentage of illiterate individuals 
(27.9%) was very similar to that in the present study. This is in 
part a reflection of the socioeconomic conditions of chagasic 
patients, who have few social opportunities, low wages and limited 
education. Dias14 explains that the disease is often associated with 
significant social losses in terms of mortality, inability to work and 
social and medical costs and that the socioeconomic context has 
allowed human Chagas’ disease to spread.
The predominant clinical form among the elderly patients 
evaluated in this study was the cardiac form, followed by the 
mixed form, for which the incidence of megaesophagus was 
higher than that of megacolon. These findings are in agreement 
with the study by Almeida et al1, who verified the cardiac form 
of Chagas’ disease in 88.5% of their chagasic patients. Chagasic 
cardiopathy is usually more common in men, as has been shown 
by a number of authors1 7 17. Coelho Jr et al12 estimated that 30% of 
individuals infected by Trypanosoma cruzi in Brazil will develop 
this type of lesion. In the present study, 62.5% of the men had 
chagasic cardiopathy, showing the importance of studying elderly 
individuals, who will very likely show alterations as a result of 
chronic heart damage.
Although chronic chagasic cardiopathy is the most serious 
lesion caused by Chagas’ disease, the mechanisms associated with 
the involvement of the heart remain poorly understood22 31. The 
majority of infected people remain asymptomatic and some 30% 
have heart and/or digestive complications in the late phase of the 
disease17. The most serious organic and functional myocardial 
damage manifests itself in only 10% of chagasic cardiac patients. 
This was observed to be true for the current study population, as 
15.9% of the elderly subjects presented with the severe form of 
chagasic cardiopathy.
In addition, it is important to note that the elderly have higher 
morbidity indices than other age groups33 55 56 58. According to 
Miller et al33, the main diseases that affect these individuals are 
DM, chronic obstructive pulmonary disease, peripheral vascular 
disease, muscular-skeletal disorders, kidney and liver disorders, 
neoplasias and neurological diseases, as well as cardiovascular 
diseases (CVDs), which receive greater attention. The literature 
on this subject emphasizes that CVDs are the main cause of 
death and morbidity in the elderly and are responsible for 18 
million deaths annually worldwide5 46 54 58. Generally speaking, 
the main heart diseases that affect the elderly are HF, coronary 
disease, hypertrophic cardiomyopathy, heart valve disease, 
supraventricular and ventricular arrhythmia and SAH54. In the 
present study, the following cardiovascular diseases were the most 
common observed: SAH, HF and ischemic heart disease.
In a study of 4,710 elderly non-chagasic North American 
patients between 1999 and 2004, Ostchega et al39 verified that 
67% of the elderly patients were suffering from hypertension, 
60% of whom were aged between 60 and 69 years-old and 72% 
of whom were women. This finding is of great importance and is 
corroborated by Lima-Costa et al25 who reported that SAH was 
the most common chronic disease in the elderly population in 
their study, 61.5% of whom were suffering from hypertension. In 
a multicenter study of a non-chagasic population, Taddei et al53 
determined a high prevalence of SAH (67%), as well as ischemic 
heart disease (29%), arrhythmias (18%), cardiomyopathy (11%) 
and HF (10%).
Particularly noteworthy is the high percentage of SAH among 
elderly sufferers of Chagas’ disease. Almeida et al1 reported a 
high incidence of SAH among elderly chagasic patients (39.3%). 
Guariento et al19 investigated chronic illnesses that coexisted with 
Chagas’ disease in a reference service. Their results showed that 
51.6% of their patients had SAH, 22.3% had other heart diseases 
arising from causes other than Trypanosoma cruzi infection, 
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19.4% had dyspepsia, 17.3% had some kind of anxiety disorder, 
11.5% had chronic lung disease and 11.1% were obese16. While 
analyzing 95 chronic chagasic patients between 22 and 89 years 
of age at Maringá University Hospital, PR, Bozelli et al8 observed 
that SAH, DM and chronic obstructive lung disease, among others, 
coexisted with Chagas’ disease in 25.3%, 10.5% and 4.2% of their 
patients, respectively. Kamiji and Oliveira24 verified DM, chronic 
kidney failure, neoplasias and Parkinson’s disease in the chagasic 
group they studied.
Guariento et al17 investigated the clinical interaction between 
Chagas’ disease and SAH and observed that greater myocardial 
damage occurred in patients with this combination of diseases 
(56%). They also determined that more serious forms of heart 
disease occurred in chagasic patients suffering from hypertension 
than in those who did not have hypertension. Bertanha et al6 
studied the characteristics of 125 chagasic patients over the age 
of 25 years-old who had been attended at the Clinic Hospital of 
Campinas State University. In their study, 55.2% of the patients had 
SAH; these were older and predominantly women and had greater 
heart damage, such as cardiac conduction disorders, extrasystoles 
and left ventricular overload.
Added to this are physiological changes due to cardiovascular 
ageing and the more common comorbidities among the elderly, 
which contribute to impairment of heart function and to clinical 
repercussions, such as hospitalization and functional decline, as 
well as to a reduction in the quality of life25 31 and the increased 
biopsychosocial vulnerability inherent to chronic processes8. 
All these factors can lead to increased morbidity and mortality 
and a reduction in the quality of life for chronic elderly patients 
suffering from Trypanosoma cruzi infection11 12.
Furthermore, the prevalence of cardiovascular diseases, 
especially ischemic heart disease and cerebrovascular disease, in 
the elderly population as a whole is known to be increasing30 38 49 
and remains an important cause of morbidity and mortality in this 
population49. A study of necropsies of patients aged 90 years-old 
or over verified that 70% of these had blocked coronary vessels, 
leading the authors to conclude that age is an independent factor 
for coronary disease54. Another study of necropsies in 92 elderly 
chagasic patients found that SAH (37%), arteriosclerosis (62%) 
and ischemic heart disease (6.5%) were also present36, showing 
the overlap between these and Chagas’ disease.
In this study, there was significant expression of CVDs in 
the chagasic population. Ischemic heart disease was observed 
in a total of 10% of the study population, which agrees with 
other studies in which this index was between 9 and 15%54. 
Coronary disease is in turn the cause of 70 to 80% of deaths 
among both men and women50 54. It should be noted that SAH 
and dyslipidemia, which are observed in 56.7% and 20% of 
elderly chagasic patients, respectively, are important factors 
in the onset and development of both ischemic heart disease 
and cerebrovascular disease. SAH is the main risk factor for 
coronary disease, HF and cerebrovascular disease in the elderly 
and is considered an independent cardiovascular factor33 34.
Studies have shown that HF is a frequent cause of 
hospitalization, morbidity and mortality among the elderly33 49 50 54. 
In a study of non-chagasic patients, Taddei et al53 reported 
a lower percentage of hospitalizations (14%), of which HF 
accounted for 31% and coronary insufficiency 25%, while 
in a study of mortality and hospitalizations among elderly 
Brazilians, Lima-Costa et al28 observed that diseases of the 
circulatory system, neoplasias and respiratory diseases were 
the main causes of death in public health services between 
1980 and 1996. Diseases of the circulatory and respiratory 
systems accounted for half of the hospitalizations and HF was 
associated with the highest percentage of hospitalizations among 
the elderly (13.6%).
In light of this, HF syndrome has been considered a 
primarily geriatric problem that has become an important 
public health problem in the 21st century due to population 
ageing46. With regard to chronic chagasic cardiopathy, a recent 
study reported that complications may include arrhythmias, 
cardiomegaly, HF and death and that this condition is an important 
cause of hospitalization and increased mortality associated with 
clinical decompensation12.
Among infectious and parasitic diseases, Chagas’ disease 
represents the second most frequent cause of death among 
elderly Brazilians. Mortality among these individuals is due to 
a cohort effect, as a result of exposure to Trypanosoma cruzi 
infection in the past. The fact that Chagas’ disease is an important 
cause of death among elderly Brazilians indicates that the 
consequences of infection are still being felt among a segment 
of this population28.
It is important to remember that a significant number of the 
elderly in the present study population were suffering from the 
cardiac form of the disease. In addition to the functional alterations 
inherent to ageing of the cardiovascular system, these patients are 
also subject to the damage associated with chagasic cardiopathy 
and other cardiovascular diseases, such as SAH and ischemic 
cardiopathy, and are consequently more vulnerable to clinical 
decompensation or the development of lesions in organs, such 
as the brain, kidneys or the heart itself.
Currently, the survival of patients with Chagas heart disease has 
increased, which may characterize the condition of survivors. It is 
noteworthy that in Brazil, the performance of heart transplantation 
and implantation of pacemakers by the Brazilian Public Health 
System (SUS) has increased. This is even cited as one of the 
reasons to explain the increased survival of Chagas in Brazil14.
Another group of diseases that predominated among the study 
population were osteoarticular diseases, of which the most notable 
were osteoporosis (23.3%) and osteoarthritis (21.1%). Ageing is 
known to increase the predisposition to osteoarticular diseases33 
and osteoarthritis and osteoporosis are among the main causes 
of morbidity among the elderly30 53. Osteoporosis is notable as it 
becomes more common with increasing age and represents a 
risk factor for skull fractures or trauma following a fall, leading 
to increased morbidity and mortality in the elderly42 44 45 56 57.
The most commonly used therapeutic agents were consistent 
with the clinical status of our elderly chagasic population, since 
the cardiac and mixed forms of the disease predominated in this 
study. The following medications were being used: ACEIs (46.7%), 
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diuretics (45.6%), platelet aggregation inhibitors (35.6%) and 
antiarrhythmic agents (20%). The finding that cardiovascular 
medication was being widely used by the elderly participants as a 
whole is consistent with the findings of other studies20 21. In spite 
of the significant percentage of elderly patients with osteoporosis 
(23.3%), few were taking medication for this condition (8.9% 
alendronate and 15.6% calcium carbonate).
Polypharmacy is an important issue among the geriatric 
population as a whole, as corroborated by Garcia16 in a study that 
observed this condition in 32% of non-chagasic individuals. In 
addition, it should be borne in mind that elderly people’s bodies 
undergo changes in their physiological functions that must be 
taken into account if the prescription is to be both rational and 
effective3 10 16 32.
A total of 77.5% of the men in the present study had up to 
four comorbidities, and in 42% of the elderly women four or 
more illnesses coexisted with Chagas’ disease. According to 
Rabelo and Cardoso42, chronic diseases are of particular interest 
in gerontological studies because they are influenced by medical, 
psychological and social factors42. For Romero48, the state of 
health declared by the elderly can to a great extent be explained 
by sex. Men are less likely to “declare themselves to be sick” than 
women. However, one aspect that deserves further investigation 
is the fact that men seek medical help less often39 46. This may to 
some extent be related to the differences between the sexes in 
so far as behavior in relation to health is concerned48 and could 
explain the greater severity and more lethal nature of Chagas’ 
disease in men (particularly those with myocardial damage) 
reported in some studies4.
It can be concluded, therefore, that elderly chagasic 
patients are a particularly vulnerable population when the 
harmful effects of a combination of Chagas’ disease and other 
chronic degenerative diseases are taken into consideration. 
Such diseases can cause severe morbidity as a result of damage 
to the cardiovascular system, a risk which is aggravated by 
polypharmacy. Finally, it is essential to highlight that the majority 
of chagasic patients are females. This phenomenon is known in 
the literature on gerontology as the process of the feminization of 
ageing. Such women, however, are at a disadvantage compared 
with men, as they not only are poorer and less educated, but also 
have more comorbidities and use a greater number of drugs.
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